Pharmacists blame middlemen for high drug costs

New study spotlights pharmacy benefit managers

AMID growing attention being paid in Massachusetts to the high cost of prescription drugs, independent pharmacists are pointing a finger at a little known culprit: the middlemen who mediate between drug manufacturers, insurers, and pharmacies.  The independent pharmacists released a study Thursday arguing that a particular pricing practice used by pharmacy benefit managers, or PBMs, is unnecessarily driving up the cost of(...)

Read More »